Epigral consolidated net profit declines 62.26% in the December 2025 quarter
Sales decline 7.46% to Rs 597.12 crore
Net profit of Epigral declined 62.26% to Rs 39.11 crore in the quarter ended December 2025 as against Rs 103.63 crore during the previous quarter ended December 2024. Sales declined 7.46% to Rs 597.12 crore in the quarter ended December 2025 as against Rs 645.24 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales597.12645.24 -7 OPM %17.2028.29 -PBDT97.31186.53 -48 PBT54.56153.62 -64 NP39.11103.63 -62Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 30 2026 | 3:52 PM IST